Malik M Keshwani1, Brandon E Aubol1, Laurent Fattet1, Chen-Ting Ma1, Jinsong Qiu2, Patricia A Jennings3, Xiang-Dong Fu2, Joseph A Adams1. 1. *Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A. 2. †Department of Cellular & Molecular Medicine, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A. 3. ‡Department of Chemistry & Biochemistry, University of California, San Diego, La Jolla, CA 92093-0636, U.S.A.
Abstract
The alternative splicing of human genes is dependent on SR proteins, a family of essential splicing factors whose name derives from a signature C-terminal domain rich in arginine-serine dipeptide repeats (RS domains). Although the SRPKs (SR-specific protein kinases) phosphorylate these repeats, RS domains also contain prolines with flanking serines that are phosphorylated by a second family of protein kinases known as the CLKs (Cdc2-like kinases). The role of specific serine-proline phosphorylation within the RS domain has been difficult to assign since CLKs also phosphorylate arginine-serine dipeptides and, thus, display overlapping residue specificities with the SRPKs. In the present study, we address the effects of discrete serine-proline phosphorylation on the conformation and cellular function of the SR protein SRSF1 (SR protein splicing factor 1). Using chemical tagging and dephosphorylation experiments, we show that modification of serine-proline dipeptides broadly amplifies the conformational ensemble of SRSF1. The induction of these new structural forms triggers SRSF1 mobilization in the nucleus and alters its binding mechanism to an exonic splicing enhancer in precursor mRNA. These physical events correlate with changes in the alternative splicing of over 100 human genes based on a global splicing assay. Overall, these studies draw a direct causal relationship between a specific type of chemical modification in an SR protein and the regulation of alternative gene splicing programmes.
The alternative splicing of human genes is dependent on n class="Gene">SR proteins, a family of essential splicing factors whose name derives from a signature C-terminal domain rich in arginine-serinedipeptide repeats (RS domains). Although the SRPKs (SR-specific protein kinases) phosphorylate these repeats, RS domains also contain prolines with flanking serines that are phosphorylated by a second family of protein kinases known as the CLKs (Cdc2-like kinases). The role of specific serine-prolinephosphorylation within the RS domain has been difficult to assign since CLKs also phosphorylate arginine-serinedipeptides and, thus, display overlapping residue specificities with the SRPKs. In the present study, we address the effects of discrete serine-prolinephosphorylation on the conformation and cellular function of the SR proteinSRSF1 (SR protein splicing factor 1). Using chemical tagging and dephosphorylation experiments, we show that modification of serine-prolinedipeptides broadly amplifies the conformational ensemble of SRSF1. The induction of these new structural forms triggers SRSF1 mobilization in the nucleus and alters its binding mechanism to an exonic splicing enhancer in precursor mRNA. These physical events correlate with changes in the alternative splicing of over 100 human genes based on a global splicing assay. Overall, these studies draw a direct causal relationship between a specific type of chemical modification in an SR protein and the regulation of alternative gene splicing programmes.
Authors: Brandon E Aubol; Ryan M Plocinik; Malik M Keshwani; Maria L McGlone; Jonathan C Hagopian; Gourisankar Ghosh; Xiang-Dong Fu; Joseph A Adams Journal: Biochem J Date: 2014-08-15 Impact factor: 3.857
Authors: A M Hartmann; D Rujescu; T Giannakouros; E Nikolakaki; M Goedert; E M Mandelkow; Q S Gao; A Andreadis; S Stamm Journal: Mol Cell Neurosci Date: 2001-07 Impact factor: 4.314
Authors: Brandon E Aubol; Ryan M Plocinik; Jonathan C Hagopian; Chen-Ting Ma; Maria L McGlone; Reeti Bandyopadhyay; Xiang-Dong Fu; Joseph A Adams Journal: J Mol Biol Date: 2013-05-23 Impact factor: 5.469
Authors: Aura M Tintaru; Guillaume M Hautbergue; Andrea M Hounslow; Ming-Lung Hung; Lu-Yun Lian; C Jeremy Craven; Stuart A Wilson Journal: EMBO Rep Date: 2007-07-13 Impact factor: 8.807
Authors: Pedro Serrano; Brandon E Aubol; Malik M Keshwani; Stefano Forli; Chen-Ting Ma; Samit K Dutta; Michael Geralt; Kurt Wüthrich; Joseph A Adams Journal: J Mol Biol Date: 2016-04-15 Impact factor: 5.469
Authors: Malik M Keshwani; Kendra L Hailey; Brandon E Aubol; Laurent Fattet; Maria L McGlone; Patricia A Jennings; Joseph A Adams Journal: Biochem J Date: 2015-10-06 Impact factor: 3.857